Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: A single-step approach

被引:126
作者
Bai, RK [1 ]
Wong, LJC [1 ]
机构
[1] Georgetown Univ, Med Ctr, Inst Mol & Human Genet, Washington, DC 20007 USA
关键词
D O I
10.1373/clinchem.2004.031153
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The A3243G mitochondrial tRNA leu(UUR) point mutation causes mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, the most common mitochondrial DNA (mtDNA) disorder, and is also found in patients with maternally inherited diabetes and deafness syndrome (MIDD). To correlate disease manifestation with mutation loads, it is necessary to measure the percentage of the A3243G mtDNA mutation. Methods: To reliably quantify low proportions of the mutant mtDNA, we developed a real-time amplification refractory mutation system quantitative PCR (ARMS-qPCR) assay. We validated the method with experimental samples containing known proportions of mutant A3243G mtDNA generated by mixing known amounts of cloned plasmid DNA containing either the wild-type or the mutant sequences. Results: A correlation coefficient of 0.9995 between the expected and observed values for the proportions of mutant A3243G in the experimental samples was found. Evaluation of a total of 36 patient DNA samples demonstrated consistent results between PCR-restriction fragment length polymorphism (RFLP) analysis and real-time ARMS-qPCR. However, the latter method was much more sensitive for detecting low percentages of mutant heteroplasmy. Three samples contained allele-specific oligonucleotide-detectable but RFLP-undetectable mutations. Conclusions: The real-time ARMS-qPCR method provides rapid, reliable, one-step quantitative detection of heteroplasmic mutant mtDNA. (C) 2004 American Association for Clinical Chemistry.
引用
收藏
页码:996 / 1001
页数:6
相关论文
共 21 条
  • [1] SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME
    ANDERSON, S
    BANKIER, AT
    BARRELL, BG
    DEBRUIJN, MHL
    COULSON, AR
    DROUIN, J
    EPERON, IC
    NIERLICH, DP
    ROE, BA
    SANGER, F
    SCHREIER, PH
    SMITH, AJH
    STADEN, R
    YOUNG, IG
    [J]. NATURE, 1981, 290 (5806) : 457 - 465
  • [2] [Anonymous], MITOMAP HUMAN MITOCH
  • [3] Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients
    Coté, HCF
    Brumme, ZL
    Craib, KJP
    Alexander, CS
    Wynhoven, B
    Ting, LL
    Wong, H
    Harris, M
    Harrigan, PR
    O'Shaughnessy, MV
    Montaner, JSG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) : 811 - 820
  • [4] DIMAURO S, 2003, MOL GENETIC BASIS NE, P189
  • [5] Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study
    Hammond, EL
    Sayer, D
    Nolan, D
    Walker, UA
    de Ronde, A
    Montaner, JSG
    Cote, HCF
    Gahan, ME
    Cherry, CL
    Wesselingh, SL
    Reiss, P
    Mallal, S
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 27 (01) : 97 - 110
  • [6] Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR
    He, LP
    Chinnery, PF
    Durham, SE
    Blakely, EL
    Wardell, TM
    Borthwick, GM
    Taylor, RW
    Turnbull, DM
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (14) : e68
  • [7] JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
  • [8] MITOMAP: a human mitochondrial genome database - 1998 update
    Kogelnik, AM
    Lott, MT
    Brown, MD
    Navathe, SB
    Wallace, DC
    [J]. NUCLEIC ACIDS RESEARCH, 1998, 26 (01) : 112 - 115
  • [9] A RAPID NONENZYMATIC METHOD FOR THE PREPARATION OF HMW DNA FROM BLOOD FOR RFLP STUDIES
    LAHIRI, DK
    NURNBERGER, JI
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (19) : 5444 - 5444
  • [10] Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO